ARCHIVES

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Panel Considers Easing Comp Center Independence Requirement, but Realizes It Lacks That Authority

February 18, 1977

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003

Sales of Smoking Cessation Aids Increase, Effectiveness Drops

October 25, 2002

NCAB: An Extraordinary Opportunity For Budgetary Coordination.

February 25, 2000

Center Studies Prevention For Endometrial Cancer

February 25, 2005